Dr. Gerald Thomas Voelbel is an Associate Professor in the Department of Occupational Therapy at New York University and an Adjunct Faculty member at Rusk Rehabilitation of New York University Langone Medical Center. His main research interests focus on the investigation of the neuropsychological deficits and cognitive remediation in neurological, psychiatric, and medical populations. He received his doctorate in psychology and neuroscience from Rutgers University. Area of significant importance for Dr. Voelbel is the development of cognitive remediation techniques to improve cognitive deficits, such as processing speed, executive function and working memory in individuals with traumatic brain injuries. An additional
Dr. Gerald Thomas Voelbel is an Associate Professor in the Department of Occupational Therapy at New York University and an Adjunct Faculty member at Rusk Rehabilitation of New York University Langone Medical Center. His main research interests focus on the investigation of the neuropsychological deficits and cognitive remediation in neurological, psychiatric, and medical populations. He received his doctorate in psychology and neuroscience from Rutgers University. Area of significant importance for Dr. Voelbel is the development of cognitive remediation techniques to improve cognitive deficits, such as processing speed, executive function and working memory in individuals with traumatic brain injuries. An additional area of interest for Dr. Voelbel is the use of functional and structural imaging methods to identify biomarkers of cognitive deficits in concussions and in more severe traumatic brain injuries. His work examines how to enhance neuroplasticity of the brain to improve cognitive functions with neuroimaging techniques.
Dr. Arnold Jonathan Wilkins is a Emeritus Professor in University of Essex Colchester, UK. He is a Professional Member of Experimental Psychology Society, British Psychological Society, British Neuropsychiatry Association. After PhD in semantic memory (with AD Baddeley as advisor) he studied as a postdoctoral fellow with B Milner at the Montreal Neurological Institute. There he carried out a study of pattern-sensitive epilepsy. The study led to an exploration of visual stress/photophobia which has continued to this day. He also discovered visual correlates of headache and showed that visual stimulation that causes seizures was responsible also for visual discomfort. These discoveries
Dr. Arnold Jonathan Wilkins is a Emeritus Professor in University of Essex Colchester, UK. He is a Professional Member of Experimental Psychology Society, British Psychological Society, British Neuropsychiatry Association. After PhD in semantic memory (with AD Baddeley as advisor) he studied as a postdoctoral fellow with B Milner at the Montreal Neurological Institute. There he carried out a study of pattern-sensitive epilepsy. The study led to an exploration of visual stress/photophobia which has continued to this day. He also discovered visual correlates of headache and showed that visual stimulation that causes seizures was responsible also for visual discomfort. These discoveries led to a general neurological theory of visual stress. The treatment of visual stress using individually prescribed ophthalmic tints evolved from this theory. He developed the first scientifically designed system of ophthalmic tinting and demonstrated its benefits in the treatment of reading disorders. With Professor Jie Huang he has shown abnormal blood oxygenation in patients with migraine in response to stressful patterns, and has shown that this abnormality can be reduced using individually prescribed ophthalmic tints. He has published three books and more than 200 publications in peer-reviewed journals. He has received support from the Medical Research Council, the Economics and Social Science Research Council, and the Wellcome Trust. His research interests centre on photophobia, photosensitive epilepsy and photosensitive migraine.
Dr. Gjumrakch Aliev, MD, PhD, President 'GALLY' International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, Atlanta, Georgia, USA as a Professor of Cardiovascular, Neuropathology, Gerontology, Health Science and Healthcare Administration. He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He received postdoctoral training with Professor G. Burnstock in the University College of the London. He authored and coauthored
Dr. Gjumrakch Aliev, MD, PhD, President 'GALLY' International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, Atlanta, Georgia, USA as a Professor of Cardiovascular, Neuropathology, Gerontology, Health Science and Healthcare Administration. He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He received postdoctoral training with Professor G. Burnstock in the University College of the London. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy. He is an outstanding teacher, scholar, and a renowned scientist in the area of cellular molecular physiology, and cardiovascular, and neurodegeneration-mediated pathologies including Alzheimer disease (AD). He is nationally and internationally reputed in his area. Dr. Aliev's accomplishments in the area of biochemistry and cellular biology have tremendous implications for drug design towards CNS Neurological Disorders, AD, cancer, and cerebrovascular and neurodegeneration related pathologies. He is world-renowned expert in electron microscopy. His work has been published in numerous prestigious journals such as Nature Clinical Cardiology, J. Neuroscience, Circulation Research, New England journal of Medicine, Blood, J. Cellular and Molecular Medicine, Atherosclerosis, CNS Neurological Disorders & Drug Targets, international J. Biochemistry and Cell Biology, and many others which reflect his leading role in his research areas. He is one of most cited authors in his fields with high impact factors.
Dr. Yoshiaki Omura received Oncological Residency Training at Cancer Institute of Columbia University & Doctor of Science Degree through research on Pharmaco-Electro-Physiology of Single Cardiac Cells in-vivo and in-vitro from Columbia University. He published over 265 original research articles, many chapters and 9 books. He is currently Adjunct Prof. of Family & Community Medicine, New York Medical College; Director of Medical Research, Heart Disease Research Foundation, New York; President and Prof. of International College of Acupuncture and Electro-Therapeutics, New York; Editor in Chief, Acupuncture & Electro-Therapeutics Research, International Journal of Integrated Medicine, which is indexed by 17 major
Dr. Yoshiaki Omura received Oncological Residency Training at Cancer Institute of Columbia University & Doctor of Science Degree through research on Pharmaco-Electro-Physiology of Single Cardiac Cells in-vivo and in-vitro from Columbia University. He published over 265 original research articles, many chapters and 9 books. He is currently Adjunct Prof. of Family & Community Medicine, New York Medical College; Director of Medical Research, Heart Disease Research Foundation, New York; President and Prof. of International College of Acupuncture and Electro-Therapeutics, New York; Editor in Chief, Acupuncture & Electro-Therapeutics Research, International Journal of Integrated Medicine, which is indexed by 17 major international Indexing Periodicals. Currently he is also Executive Editor of Integrative Oncology. Formerly, he was also Adjunct Prof. or Visiting Prof. in Universities in USA, France, Italy, Ukraine, Japan and China. His main research titles are Early non-invasive quick diagnosis of various cancers, memory and behavioral problems, cardiovascular problems and their safe, affective, individualized treatment. His Research Keywords: Autism; Alzheimer's disease, Memory Loss, Abnormal behavior, Hippocampus, Non-invasive Quick Economical Measurement of Neurotransmitter, Acetylcholine, Serotonin, Dopamine GABA, Brain Tumor, Glioblastoma, Anaplastic Astrocytoma, Headaches, Bone Marrow Related Malignancy.
Dr. Alvaro Frias Ibanez is an Assistant Professor at University of Ramon-Llull, Barcelona, Spain. He is also a Director of Clinical Psychology Residency Program in the Department of Psychiatry in Hospital of Mataro. He is a Clinical Psychologist in Child/Youth & Adult Outpatient Mental Health Services; Bipolar Disorder Center, La Fe Hospital; Adult Partial Hospitalization Service, Pare Jofre Psiquiatric Hospital; Long-Term Hospital Care, Psychiatric Hospital of Betera, Valencia, Spain. His Academic awards and grants include Alicia Koplowitz's grant for international research stays, V Segles predoctoral research grant, University of Valencia. His areas of expertise are Comorbidity, phenomenology, risk factors
Dr. Alvaro Frias Ibanez is an Assistant Professor at University of Ramon-Llull, Barcelona, Spain. He is also a Director of Clinical Psychology Residency Program in the Department of Psychiatry in Hospital of Mataro. He is a Clinical Psychologist in Child/Youth & Adult Outpatient Mental Health Services; Bipolar Disorder Center, La Fe Hospital; Adult Partial Hospitalization Service, Pare Jofre Psiquiatric Hospital; Long-Term Hospital Care, Psychiatric Hospital of Betera, Valencia, Spain. His Academic awards and grants include Alicia Koplowitz's grant for international research stays, V Segles predoctoral research grant, University of Valencia. His areas of expertise are Comorbidity, phenomenology, risk factors and nosological status related to: Obsessive-compulsive disorder, Schizophrenia, Post-traumatic stress disorder, Borderline personality disorder, Pediatric bipolar disorder, Paraphilic disorders.
Dr. Shengwen Calvin Li is a Principal Investigator (PI) and Head, Neuro-Oncology and Stem Cell Research Laboratory, CHOC Children's Hospital, University of California-Irvine. He is also a Adjunct professor at California State University Fullerton,CA; Sun Yat-sen University, School of Marine Science, China; Thomas Jefferson University Stem Cell Biology and Regenerative Medicine Center, Philadelphia, PA. He has been a member of Association for Clinical and Translational Science, Society for Translational and Clinical Sciences, International Society of Stem Cell Research, Society for Neuroscience, American Society for Cell Biology, American Association for the Advancement of Science, and American Society of Investigative Pathology. His
Dr. Shengwen Calvin Li is a Principal Investigator (PI) and Head, Neuro-Oncology and Stem Cell Research Laboratory, CHOC Children's Hospital, University of California-Irvine. He is also a Adjunct professor at California State University Fullerton,CA; Sun Yat-sen University, School of Marine Science, China; Thomas Jefferson University Stem Cell Biology and Regenerative Medicine Center, Philadelphia, PA. He has been a member of Association for Clinical and Translational Science, Society for Translational and Clinical Sciences, International Society of Stem Cell Research, Society for Neuroscience, American Society for Cell Biology, American Association for the Advancement of Science, and American Society of Investigative Pathology. His Research Interest: Pediatric brain tumor biology, stem cell differentiation mechanisms, stem cell-based therapy, engineered tissue graft (ETG), engineer-design matrix for cell culture, Caveolin-mediated signal transduction, immunotherapy of cancer.
Dr. Terry Lichtor is a Associate Professor of Neurosurgery, Rush University, USA. His Professional Society memberships include National Directory of Spine Physicians, European Society for Cancer Immunology and Immunotherapy, Society for Neuro-Oncology, Joint Section on Tumors, The American Association of Neurological Surgeons and Congress of Neurological Surgeons, American College of Surgeons. His major research interests are Gene Therapy Strategies in the Treatment of Brain Tumors, Development of Brain Tumor Vaccines, Development of MRI Technology for Measurement of Intracranial Pressure, Molecular Strategies in the Treatment of Alzheimer's Disease.
Dr. Terry Lichtor is a Associate Professor of Neurosurgery, Rush University, USA. His Professional Society memberships include National Directory of Spine Physicians, European Society for Cancer Immunology and Immunotherapy, Society for Neuro-Oncology, Joint Section on Tumors, The American Association of Neurological Surgeons and Congress of Neurological Surgeons, American College of Surgeons. His major research interests are Gene Therapy Strategies in the Treatment of Brain Tumors, Development of Brain Tumor Vaccines, Development of MRI Technology for Measurement of Intracranial Pressure, Molecular Strategies in the Treatment of Alzheimer's Disease.
Dr. Ilya Ulasov is a staff scientist and principal investigator at the Swedish Neuroscience Institute of Swedish Medical Center in Seattle, WA. He is a translational cancer biologist focusing on intervention for glioblastoma multiforme and cell signaling in brain metastases using experimental viral (adenovirus) and non-viral (nanoparticles) approaches. In particular, Dr. Ulasov and his collaborators are working toward the design of cancer-specific, recombinant, self-replicated, adenoviral vectors. Using transcriptomic and proteomic assays, Dr. Ulasov searches for tumor-specific targets for gene and drug therapy, and he aims to design comprehensive translational approaches to target tumor-initiated and tumor-circulated stem cells resistant to radiation
Dr. Ilya Ulasov is a staff scientist and principal investigator at the Swedish Neuroscience Institute of Swedish Medical Center in Seattle, WA. He is a translational cancer biologist focusing on intervention for glioblastoma multiforme and cell signaling in brain metastases using experimental viral (adenovirus) and non-viral (nanoparticles) approaches. In particular, Dr. Ulasov and his collaborators are working toward the design of cancer-specific, recombinant, self-replicated, adenoviral vectors. Using transcriptomic and proteomic assays, Dr. Ulasov searches for tumor-specific targets for gene and drug therapy, and he aims to design comprehensive translational approaches to target tumor-initiated and tumor-circulated stem cells resistant to radiation and chemotherapy. Recently, Dr. Ulasov and collaborators identified a lack of autophagy response in glioma stem cells mediated by human cytomegalovirus. Dr. Ulasov’s research into oncolytic adenoviruses in the presence of drugs that promote autophagy may improve the targeting of glioma stem cells, which could have a significant impact on clinical treatment of glioma. His research interests: gene therapy, oncolytic adenoviruses, brain metastases and glioblastoma multiforme, mechanisms of cancer cells resistance to the therapy and adenovirus infection.
Dr. Hassaan Tohid is a visiting Neuroscientist at Center for Mind & Brain, University of California, Davis, USA. He is a member of American Neuropsychiatric Association and also for Leadership Council, American Cancer Society. His research interests include: Neuroimaging, fMRI, EEG, denial (defense mechanism), Epilepsy, Psychogenic seizures, Neurodegeneration, Mirror neurons, Autism and autism spectrum, Psychosomatics, Psychodermatology, Neurosurgery, Cultural psychiatry, Social psychiatry, Different techniques of neuroimaging, Nanotechnology and its relevance to neuroimaging, Psychopharmacology, Anti-GAD syndrome and Stiff person syndrome, Schizophrenia, Psychosis, Dissociative identity disorder, Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis and Stroke.
Dr. Hassaan Tohid is a visiting Neuroscientist at Center for Mind & Brain, University of California, Davis, USA. He is a member of American Neuropsychiatric Association and also for Leadership Council, American Cancer Society. His research interests include: Neuroimaging, fMRI, EEG, denial (defense mechanism), Epilepsy, Psychogenic seizures, Neurodegeneration, Mirror neurons, Autism and autism spectrum, Psychosomatics, Psychodermatology, Neurosurgery, Cultural psychiatry, Social psychiatry, Different techniques of neuroimaging, Nanotechnology and its relevance to neuroimaging, Psychopharmacology, Anti-GAD syndrome and Stiff person syndrome, Schizophrenia, Psychosis, Dissociative identity disorder, Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis and Stroke.
Dr. Nadejda M Tsankova is an Assistant Professor in Pathology and Neuroscience at the Icahn School of Medicine at Mount Sinai. Her laboratory studies the molecular mechanisms of gliomagenesis in endogenous human-based models. She is also a practicing neuropathologist, specializing in the diagnoses of complex neurological disorders including epilepsy, inflammatory and neurodegenerative conditions, and brain tumors. She received her M.D./Ph.D. from UT Southwestern Medical Center, where she pioneered the studies of neuroepigenetics in chronic stress/depression with Dr. Eric Nester. Following the path of a Physician-Scientist, she then completed her residency in Anatomic Pathology and fellowship in Neuropathology at Columbia University,
Dr. Nadejda M Tsankova is an Assistant Professor in Pathology and Neuroscience at the Icahn School of Medicine at Mount Sinai. Her laboratory studies the molecular mechanisms of gliomagenesis in endogenous human-based models. She is also a practicing neuropathologist, specializing in the diagnoses of complex neurological disorders including epilepsy, inflammatory and neurodegenerative conditions, and brain tumors. She received her M.D./Ph.D. from UT Southwestern Medical Center, where she pioneered the studies of neuroepigenetics in chronic stress/depression with Dr. Eric Nester. Following the path of a Physician-Scientist, she then completed her residency in Anatomic Pathology and fellowship in Neuropathology at Columbia University, where she became intrigued with studying the pathogenesis of human gliomas. Working in the laboratory of Dr. Fiona Doetsch, she developed novel techniques to isolate endogenous neural progenitors from human brain, creating a transitional system to study molecular dysregulation during gliomagenesis. Previously an Assistant Professor at Columbia University and now one at Mount Sinai, Dr. Tsankova also has fruitful and ongoing collaborations with several investigators from the departments of Neurosurgery, Neuroscience, and Psychiatry.
Dr. Liam Chen is an Assistant Professor in Pathology at the Johns Hopkins University School of Medicine. He is also a practicing neuropathologist, specializing in the diagnoses of complex neurological disorders including brain tumors, inflammatory and neurodegenerative conditions. Dr. Chen received residency training in Anatomic Pathology and fellowship training in Neuropathology and Molecular Genetic Pathology at Harvard Medical School. His laboratory is focused on understanding the molecular mechanisms underlying neurodegeneration in human disorder. His laboratory takes advantage of a simple animal model, Drosophila melanogaster, to harness the power of genetics to define cellular pathways underlying the specific destruction of postmitotic
Dr. Liam Chen is an Assistant Professor in Pathology at the Johns Hopkins University School of Medicine. He is also a practicing neuropathologist, specializing in the diagnoses of complex neurological disorders including brain tumors, inflammatory and neurodegenerative conditions. Dr. Chen received residency training in Anatomic Pathology and fellowship training in Neuropathology and Molecular Genetic Pathology at Harvard Medical School. His laboratory is focused on understanding the molecular mechanisms underlying neurodegeneration in human disorder. His laboratory takes advantage of a simple animal model, Drosophila melanogaster, to harness the power of genetics to define cellular pathways underlying the specific destruction of postmitotic neurons in neurodegenerative disorders. Using this approach, Dr. Chen's laboratory has created new fruit fly models of several human diseases, including frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), and chronic traumatic encephalopathy. Now working as an independent principal investigator at Johns Hopkins, he also has fruitful and ongoing collaborations with several investigators from the departments of Neurosurgery, Neuroscience, and Pathology.
Dr. Khue Vu Nguyen is currently Full Project Scientist in the Departments of Medicine and Pediatrics, University of California, San Diego, School of Medicine, San Diego, California, USA. He has studied at University Louis Pasteur, Strasbourg, France: B.S. in Biochemistry, M.S. in Molecular Biology, Ph.D. in Macromolecular Physical Chemistry, Ph.D. in Physical Sciences (Doctorat d'Etat es Sciences Physiques). Dr. Nguyen has worked as Scientist in different French and U.S. Research Institutions and Companies. He is author and co-author of numerous publications and holder of many patents. Dr. Nguyen is listed in Who's Who in the World, Who's Who in America,
Dr. Khue Vu Nguyen is currently Full Project Scientist in the Departments of Medicine and Pediatrics, University of California, San Diego, School of Medicine, San Diego, California, USA. He has studied at University Louis Pasteur, Strasbourg, France: B.S. in Biochemistry, M.S. in Molecular Biology, Ph.D. in Macromolecular Physical Chemistry, Ph.D. in Physical Sciences (Doctorat d'Etat es Sciences Physiques). Dr. Nguyen has worked as Scientist in different French and U.S. Research Institutions and Companies. He is author and co-author of numerous publications and holder of many patents. Dr. Nguyen is listed in Who's Who in the World, Who's Who in America, etc. He is member of different academic organizations such as American Society for Microbiology, American Chemical Society. Dr. Nguyen is invited reviewer and editorial board of different scientific journals. He is Scientist Reviewer for grant proposals of the Metabolic Disease Two (MB-2) of the Peer Review Medical Research Program (PRMRP) for the U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP). Dr. Khue Vu Nguyen Current research interest includes genetic diseases, neurodevelopmental and neurodegenerative disorders, and cancer.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97